WebCytokinetics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CYTK financial statements in full. WebCYTK Finanicals Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert After Hours Last Updated: Mar 8, 2024 …
CYTOKINETICS, INCORPORATED : Financial Data Forecasts …
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … Web18 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/03/23-4:00PM EST GlobeNewswire 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts desert oasis recreation center
Cytokinetics Inc. Financials CYTK Barron
WebApr 11, 2024 · Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 33.36 -0.27 (-0.80%) At close: 04:00PM EDT 33.36 0.00 (0.00%) After hours: 04:11PM EDT Time... WebNov 4, 2024 · Inside Cytokinetics Inc's 10-Q Quarterly Report: Financial - Expense Highlight. Each of these adjustments is accounted for on a prospective basis in our liability calculation and resulted in a decline in our imputed interest rate and noncash interest expenses from 10% and $4.4 million in the second quarter of 2024 to 7.5% and $3.4 … WebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., March 01, 2024(GLOBE NEWSWIRE) -- Cytokinetics, Incorporated(Nasdaq: CYTK) reported financial results for the fourth quarter and full year 2024. Net loss for the fourth quarter was $137.4 millionor $1.45per share and the net loss for the year 2024 was $389.0 millionor $4.33per share. desert of saudi arabia